bacitracin-a and undecaprenyl-pyrophosphate

bacitracin-a has been researched along with undecaprenyl-pyrophosphate* in 1 studies

Other Studies

1 other study(ies) available for bacitracin-a and undecaprenyl-pyrophosphate

ArticleYear
High-resolution crystal structure reveals molecular details of target recognition by bacitracin.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Aug-27, Volume: 110, Issue:35

    Bacitracin is a metalloantibiotic agent that is widely used as a medicine and feed additive. It interferes with bacterial cell-wall biosynthesis by binding undecaprenyl-pyrophosphate, a lipid carrier that serves as a critical intermediate in cell wall production. Despite bacitracin's broad use, the molecular details of its target recognition have not been elucidated. Here we report a crystal structure for the ternary complex of bacitracin A, zinc, and a geranyl-pyrophosphate ligand at a resolution of 1.1 Å. The antibiotic forms a compact structure that completely envelopes the ligand's pyrophosphate group, together with flanking zinc and sodium ions. The complex adopts a highly amphipathic conformation that offers clues to antibiotic function in the context of bacterial membranes. Bacitracin's efficient sequestration of its target represents a previously unseen mode for the recognition of lipid pyrophosphates, and suggests new directions for the design of next-generation antimicrobial agents.

    Topics: Amino Acid Sequence; Bacitracin; Cell Membrane; Crystallography, X-Ray; Models, Molecular; Molecular Sequence Data; Polyisoprenyl Phosphates; Protein Binding; Protein Conformation; Surface Plasmon Resonance

2013